Company profile · Riga, Latvia

State Agency of Medicines Latvia

Medicines Regulation, GMP Inspection, Pharmacovigilance, and Device Oversight · National medicines regulator

LatviaRegulatory anchorRiga

National regulatory hub for authorisations, inspections, and medicines supervision across Latvia's manufacturing layer.

Lead
Indra Dreika (verified ↗)
Address
Jersikas iela 15, Riga LV-1003, Latvia (source ↗)
Compliance
Not yet on record
Last reviewed
15 Mar 2026 (3mo ago)
Scale
National medicines regulator
Capabilities
Marketing authorisation review · GMP/GDP inspections · Pharmacovigilance control
Founded
1996
Headcount
51-200
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Indra Dreika

Director

Check official leadership source
Full addressJersikas iela 15, Riga LV-1003, Latvia
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official Zāļu valsts aģentūra contacts page and map pin listing Jersikas iela 15 in Riga.

Open source
Operating profile

National medicines regulator

Riga, Latvia. Medicines Regulation, GMP Inspection, Pharmacovigilance, and Device Oversight. Review completed on 15 Mar 2026.

2026 technical specializationMedicines Regulation, GMP Inspection, Pharmacovigilance, and Device Oversight
Core capabilities
Marketing authorisation reviewGMP/GDP inspectionsPharmacovigilance controlMedicines market supervision
Governance

Latvian Ministry of Health and EU medicines regulatory framework

National medicines-control authority, EU regulatory enforcement

Editorial note

Medicines Regulation, GMP Inspection, Pharmacovigilance, and Device Oversight

National regulatory hub for authorisations, inspections, and medicines supervision across Latvia's manufacturing layer.

Related companies
Editorial note

ZVA functions as Latvia's medicines regulator and inspection authority, directly shaping the regulatory posture of the Riga pharmaceutical backbone.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 15 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Marketing authorisation review
GMP/GDP inspections
Pharmacovigilance control
Medicines market supervision
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceZVA official director page confirming Indra Dreika.Source origin: zva.gov.lvOpen source
Supporting evidenceZVA public agency overview for Latvian medicines-control functions.Source origin: zva.gov.lvOpen source
Physical-site evidenceOfficial Zāļu valsts aģentūra contacts page and map pin listing Jersikas iela 15 in Riga.Source origin: zva.gov.lvOpen source
Infrastructure

Declared infrastructure

Inspection directorate
Licensing systems
Regulatory reporting offices
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

15 Mar 2026: Executive identity confirmed via official management disclosure.
15 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is State Agency of Medicines Latvia located?
State Agency of Medicines Latvia operates from Jersikas iela 15, Riga LV-1003, Latvia, Riga, Latvia.
Who runs State Agency of Medicines Latvia?
State Agency of Medicines Latvia is led by Indra Dreika, Director. Verified 15 Mar 2026.
What does State Agency of Medicines Latvia do?
National regulatory hub for authorisations, inspections, and medicines supervision across Latvia's manufacturing layer. Core capabilities: Marketing authorisation review, GMP/GDP inspections, Pharmacovigilance control, Medicines market supervision.
Editorial context

Related technical briefs

Briefs that name Riga as a covered market or city.